Control of Japanese encephalitis in Asia: the time is now

Details

• Alternative Title:
  Expert Rev Anti Infect Ther
• Personal Author:
  Hills, Susan ; Martin, Rebecca ; Marfin, Anthony ; Fischer, Marc
• Description:
  Japanese encephalitis (JE) virus is the most common vaccine-preventable cause of encephalitis in Asia. Recent progress in the development and availability of improved JE vaccines has revitalized the prospects for JE control. There now are a number of safe and effective vaccines, two WHO prequalified vaccines available for pediatric use, at least one vaccine considered affordable for use in lower income countries, and a GAVI Alliance commitment to provide financial support to eligible countries for campaigns for children aged 9 months through 14 years. While challenges remain, this tremendous progress means there is a better opportunity than at any time in the past to prevent the substantial morbidity and mortality from this disease.
• Subjects:
  Asia Communicable Disease Control Encephalitis, Japanese Encephalitis Virus, Japanese Humans Japanese Encephalitis Vaccines
• Source:
  Expert Rev Anti Infect Ther. 12(8):901-904
• Pubmed ID:
  24927959
• Pubmed Central ID:
  PMC4594829
• Document Type:
  Journal Article
• Funding:
  CC999999/Intramural CDC HHSUnited States/
• Volume:
  12
• Issue:
  8
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:315ba8d6c99e663d9021e367bd8fc2c88a8864a6e5cd9682de84c1a3e5211f22
• Download URL:
  https://stacks.cdc.gov/view/cdc/34832/cdc_34832_DS1.pdf
• File Type:
  [PDF - 55.85 KB ]